Thomas W Kensler Selected Research

Thomas W Kensler Research Topics

Disease

51	Neoplasms (Cancer) 03/2021 - 01/2002
28	Carcinogenesis 01/2021 - 02/2002
15	Inflammation (Inflammations) 08/2020 - 11/2004
15	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 02/2003
14	Liver Neoplasms (Liver Cancer) 02/2019 - 08/2002
8	Hyperoxia 11/2020 - 01/2002
8	Infections 02/2019 - 08/2002
7	Breast Neoplasms (Breast Cancer) 07/2020 - 08/2008
7	Lung Injury 05/2013 - 02/2002
7	Chronic Disease (Chronic Diseases) 04/2012 - 12/2003
5	Insulin Resistance 01/2018 - 02/2008
5	Body Weight (Weight, Body) 07/2015 - 02/2006
4	Fibrosis (Cirrhosis) 01/2021 - 04/2010
4	Lung Diseases (Lung Disease) 05/2013 - 01/2002
4	Critical Illness (Critically Ill) 05/2013 - 12/2007
4	Acute Lung Injury 11/2009 - 12/2007
3	Obesity 02/2016 - 10/2009
3	Chronic Obstructive Pulmonary Disease (COPD) 02/2009 - 11/2004
3	Emphysema 01/2009 - 11/2004
3	Neuroblastoma 09/2007 - 07/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 02/2016
2	Chronic Renal Insufficiency 01/2021 - 01/2018
2	Cardiomyopathies (Cardiomyopathy) 01/2020 - 10/2013
2	Squamous Cell Carcinoma of Head and Neck 07/2016 - 06/2015
2	Lung Neoplasms (Lung Cancer) 01/2016 - 01/2014
2	Persistent Infection 10/2013 - 09/2013
2	Parkinson Disease (Parkinson's Disease) 01/2013 - 12/2006
2	Asthma (Bronchial Asthma) 10/2008 - 07/2005
2	Septic Shock (Toxic Shock Syndrome) 04/2006 - 04/2006
2	Pneumonia (Pneumonitis) 04/2006 - 11/2004
2	Hepatitis B 09/2003 - 02/2003
2	Hypercalcemia (Milk Alkali Syndrome) 07/2003 - 04/2002
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022
1	Gallstones (Gallstone) 01/2022

Drug/Important Bio-Agent (IBA)

26	AflatoxinsIBA 11/2019 - 08/2002
25	EnzymesIBA 01/2021 - 02/2002
20	AntioxidantsIBA 11/2020 - 02/2002
14	Biomarkers (Surrogate Marker)IBA 08/2020 - 02/2003
14	CarcinogensIBA 08/2020 - 09/2002
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2002
13	Transcription Factors (Transcription Factor)IBA 04/2019 - 02/2002
12	sulforaphaneIBA 01/2021 - 05/2002
11	Aflatoxin B1 (Aflatoxin B)IBA 11/2017 - 02/2003
10	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 01/2021 - 02/2006
10	oltiprazIBA 08/2020 - 08/2002
10	TriterpenesIBA 11/2017 - 02/2006
8	DNA AdductsIBA 07/2014 - 02/2003
7	Oxidants (Oxidizing Agents)IBA 06/2013 - 01/2002
6	Glutathione (Reduced Glutathione)IBA 01/2020 - 02/2002
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 01/2002
6	Oxidoreductases (Dehydrogenase)IBA 04/2011 - 02/2002
6	1,2-dithiol-3-thioneIBA 08/2009 - 03/2003
5	SmokeIBA 01/2014 - 11/2004
5	Oxygen (Dioxygen)IBA 05/2013 - 01/2002
5	DNA (Deoxyribonucleic Acid)IBA 04/2012 - 02/2002
5	Environmental CarcinogensIBA 01/2012 - 03/2003
5	NF-E2-Related Factor 2IBA 04/2011 - 11/2007
4	isothiocyanic acidIBA 07/2020 - 07/2007
4	Estrogens (Estrogen)FDA Link 07/2020 - 08/2008
4	Fatty Acids (Saturated Fatty Acids)IBA 07/2020 - 10/2004
4	imidazoleIBA 11/2019 - 02/2006
4	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2017 - 09/2007
4	LipidsIBA 02/2016 - 10/2009
4	bardoxoloneIBA 01/2014 - 01/2009
4	NAD (NADH)IBA 04/2011 - 02/2002
4	quinone (benzoquinone)IBA 04/2011 - 02/2002
4	chlorophyllin (copper chlorophyll)IBA 03/2007 - 08/2002
3	bardoxolone methylIBA 01/2021 - 11/2007
3	IsothiocyanatesIBA 01/2019 - 07/2007
3	Insulin (Novolin)FDA Link 01/2018 - 07/2015
3	Messenger RNA (mRNA)IBA 01/2017 - 02/2002
3	Pharmaceutical PreparationsIBA 02/2012 - 11/2004
3	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2007 - 07/2006
2	NF-E2 Transcription FactorIBA 08/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 11/2019 - 11/2017
2	Drinking WaterIBA 02/2019 - 01/2014
2	MicrocystinsIBA 02/2019 - 01/2014
2	Kelch-Like ECH-Associated Protein 1IBA 01/2019 - 01/2010
2	PhytochemicalsIBA 02/2016 - 02/2012
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 07/2015
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 05/2013 - 11/2003
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2013 - 12/2006
2	TransferasesIBA 04/2011 - 02/2002
2	LuciferasesIBA 11/2010 - 11/2003
2	Lysine (L-Lysine)FDA Link 03/2010 - 03/2008
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2008 - 04/2006
2	ATP dependent 26S protease (26S proteasome)IBA 09/2007 - 12/2003
2	Free RadicalsIBA 08/2007 - 10/2002
2	ChlorophyllIBA 06/2007 - 02/2003
2	Basic-Leucine Zipper Transcription FactorsIBA 12/2006 - 04/2006
2	NADP (NADPH)IBA 09/2006 - 02/2004
2	Benzo(a)pyreneIBA 03/2003 - 05/2002
2	KetonesIBA 04/2002 - 01/2002
1	Coloring Agents (Dyes)IBA 01/2022

Therapy/Procedure

19	Chemoprevention 03/2021 - 08/2002
6	Therapeutics 01/2016 - 12/2007
4	Oral Administration 01/2013 - 06/2007
3	Drug Therapy (Chemotherapy) 08/2008 - 01/2002
2	Critical Care (Surgical Intensive Care) 05/2013 - 04/2006
2	Ligation 05/2012 - 04/2006